These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25568574)

  • 1. Exhausting multiple hemodialysis access failures.
    Bolleke E; Seferi S; Rroji M; Idrizi A; Barbullushi M; Thereska N
    Med Arch; 2014 Oct; 68(5):361-3. PubMed ID: 25568574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].
    Rodríguez CR; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():105-12. PubMed ID: 19018747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of vascular access in hemodialysis patients: a report from a dialysis unit in Casablanca.
    Medkouri G; Aghai R; Anabi A; Yazidi A; Benghanem MG; Hachim K; Ramdani B; Zaid D
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):516-20. PubMed ID: 17186686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Types of hemodialysis vascular access in patients on renal replacement therapy and its complications during a one year observation period].
    Krzanowski M; Janda K; Chowaniec E; Kuśnierz-Cabala B; Sułowicz W
    Przegl Lek; 2011; 68(7):343-7. PubMed ID: 22010469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis.
    O'shea SI; Lawson JH; Reddan D; Murphy M; Ortel TL
    J Vasc Surg; 2003 Sep; 38(3):541-8. PubMed ID: 12947274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinal approach to the placement of tunneled hemodialysis catheters in patients with central vein occlusion in an outpatient access center.
    Matsuura J; Dietrich A; Steuben S; Ricker J; Barkema K; Kuhl T
    J Vasc Access; 2011; 12(3):258-61. PubMed ID: 21104666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
    Shafi ST; Gupta M
    J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vascular access for hemodialysis after successful kidney transplantation.
    Patard JJ; Bensalah K; Lucas A; Rodriguez A; Manunta A; Rivalan J; Le Pogamp P; Lobel B; Guillé F
    Scand J Urol Nephrol; 2002; 36(5):373-6. PubMed ID: 12487743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis.
    Colì L; Donati G; Cianciolo G; Raimondi C; Comai G; Panicali L; Nastasi V; Cannarile DC; Gozzetti F; Piccari M; Stefoni S
    J Vasc Access; 2006; 7(3):118-22. PubMed ID: 17019663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular access thrombosis and interventions in patients missing hemodialysis sessions.
    Shah R; Bhatt UY; Cleef SV; Farley M; Davis A; Swope M; Agarwal AK
    Clin Nephrol; 2011 Dec; 76(6):435-9. PubMed ID: 22105445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
    Al Shakarchi J; Inston N; Jones RG; Maclaine G; Hollinworth D
    J Vasc Surg; 2016 Apr; 63(4):1026-33. PubMed ID: 26826055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular access validity and treatment efficiency in hemodialysis].
    Ferrari G; Talassi E; Baraldi C; Lambertini D; Tarchini R
    G Ital Nefrol; 2003; 20 Suppl 22():S22-9. PubMed ID: 12851917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report.
    Sofue T; Hayashida Y; Hara T; Kawakami K; Ueda N; Kushida Y; Inui M; Dobashi H; Kakehi Y; Kohno M
    BMC Nephrol; 2014 Oct; 15():167. PubMed ID: 25319344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.